STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31

Shattuck Labs, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$5.37−0.05 (-0.92%)

Close on Oct 19, 2026

Market cap: $696.91M
P/E (TTM): –
Dividend yield: –

Shattuck Labs, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Cash & Equivalents	54	57	126	47	92	158	7.01	32
Short-Term Investments	–	–	5.00	114	177	178	32	–
Cash & Short-Term Investments	78	73	131	161	269	335	39	32
Prepaid Expenses & Other	4.41	6.23	13	23	19	10	3.36	–
Total Current Assets	82	79	143	185	288	346	42	–
Property, Plant & Equipment	6.11	9.81	14	18	9.94	3.00	2.44	–
Gross Property, Plant & Equipment	23	23	23	23	13	4.48	3.30	–
Accumulated Depreciation	-17	-13	-9.51	-5.71	-2.78	-1.48	-0.86	–
Operating Lease Right-of-Use Assets	1.34	1.84	2.27	2.64	–	–	–	–
Other Long-Term Assets	1.44	2.02	2.54	3.07	0.38	0.35	0.09	–
Total Assets	91	91	160	205	299	349	45	–
Accounts Payable	2.10	2.42	1.59	7.17	10	1.75	3.05	–
Current Portion of Leases	0.84	0.90	0.80	0.70	–	–	–	–
Deferred Revenue (Current)	–	–	0.34	0	0	7.73	13	–
Total Current Liabilities	7.05	8.92	11	25	25	17	20	–
Long-Term Leases	1.58	2.51	3.41	4.20	0	–	–	–
Operating Lease Liabilities	2.42	3.41	4.20	4.90	0	–	–	–
Total Liabilities	8.64	11	15	29	27	39	30	–
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.00	–
Additional Paid-In Capital	513	461	451	396	389	382	0.89	–
Retained Earnings	-431	-382	-306	-219	-117	-72	-35	–
Comprehensive Income & Other	0.01	0.00	0.00	-0.88	-0.56	-0.06	0.05	–
Shareholders' Equity	82	80	145	176	272	310	-35	-11
Total Equity	82	80	145	176	272	310	-35	-11
Total Liabilities & Equity	91	91	160	205	299	349	45	–
Shares Outstanding(shares)	63	48	47	42	42	42	7.60	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -5578.7%
Net margin: -5256.8%
Return on equity, FY2025: -60.3%

Financial strength

Current ratio: 27.59
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 818.8%

Valuation

P/E ratio: –
Price to sales: 696.91
Price to book: 3.30
Dividend yield: –